ERASynBio: Induced Evolution of Synthetic Yeast Genomes

ERASynBio：合成酵母基因组的诱导进化

• 批准号: 1445537
• 负责人: Jef Boeke
• 金额: $ 42.74万
• 依托单位: New York University Medical Center
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-15 至 2017-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1445537&HistoricalAwards=false
• 关键词: ERASynBio; Induced; Evolution; Synthetic; Yeast

This project, funded by the Systems and Synthetic Biology Program in MCB and the Biotechnology, Biochemical and Biomass Engineering Program in CBET, is part of a larger ERASynBio funded collaborative. The researchers have previously developed the capability to design and synthesize entire yeast chromosomes, and have inserted into the chromosomes sites that make it easy to modify or recombine pieces of the chromosome. In this work, they leverage this capability to evolve yeast strains that will be particularly well suited for production of chemicals or fuels or other biomanufacturing tasks. In addition, they will collect data that will help them address questions about how chromosomes evolve in laboratory or manufacturing settings, and what characteristics give rise to more stable chromosomes and better growing yeast strains. At the same time, the researchers will develop on line courses to teach ethics related to the field of synthetic biology, and expand their laboratory classes that enable undergraduates to synthesize parts of the yeast chromosome and learn the tools needed to enter into this research field. Technical Description: Induced Evolution of Synthetic Yeast genomes (IESY) will use the first synthetic eukaryote, Saccharomyces cerevisiae 2.0 (Sc2.0), as a platform for metabolic engineering and genome minimization, and more importantly for generating and understanding industrially high-value phenotypes. Synthetic chromosomes in Sc2.0 permit rapid and comprehensive genome evolution through synthetic chromosome rearrangement and modification by loxP-mediated evolution (SCRaMbLE). SCRaMbLE will be exploited here to evolve strains selected for high-value phenotypes for biofuels and biotechnology, using both chemostats and batch transfer methods in the USA and Europe. Technologies for neochromosomes and orthogonal SCRaMbLE of gene classes will be developed. Evolutionary trajectories will be analyzed to relate genome structure with genome function: DNA sequencing will reveal the genome sequence, rearrangements, and copy number changes in the evolved strains; chromosome conformation capture will show how massive rearrangements affect 3D structure; and deep sequencing technologies will relate sequence and structure to gene expression and isoform abundance. Computational analysis will identify the evolutionary drivers for high fitness, with the potential for further optimization. IESY builds on resources uniquely available from the international Sc2.0 consortium and will be an international resource for efficient evolution of high-value phenotypes. This project represents a new paradigm in synthetic biology in which a genome is pre-programmed to explore combinatorial diversity space to evolve new and useful function.

该项目由 MCB 的系统和合成生物学项目以及 CBET 的生物技术、生物化学和生物质工程项目资助，是 ERASynBio 资助的更大合作项目的一部分。 研究人员此前已经开发出设计和合成整个酵母染色体的能力，并将其插入染色体位点，从而可以轻松修改或重组染色体片段。 在这项工作中，他们利用这种能力来进化酵母菌株，这些菌株特别适合化学品或燃料的生产或其他生物制造任务。 此外，他们还将收集数据，帮助他们解决有关染色体在实验室或制造环境中如何进化，以及哪些特征产生更稳定的染色体和更好生长的酵母菌株的问题。 与此同时，研究人员将开发在线课程来教授与合成生物学领域相关的伦理学，并扩大他们的实验室课程，使本科生能够合成部分酵母染色体并学习进入该研究领域所需的工具。技术说明：合成酵母基因组诱导进化 (IESY) 将使用第一个合成真核生物酿酒酵母 2.0 (Sc2.0)，作为代谢工程和基因组最小化的平台，更重要的是用于生成和理解工业高价值表型。 Sc2.0 中的合成染色体通过 loxP 介导的进化 (SCRaMbLE) 进行合成染色体重排和修饰，允许快速、全面的基因组进化。 SCRaMbLE 将在美国和欧洲使用恒化器和批量转移方法，用于进化为生物燃料和生物技术的高价值表型选择的菌株。将开发新染色体和基因类别正交 SCRaMbLE 技术。将分析进化轨迹，将基因组结构与基因组功能联系起来：DNA测序将揭示进化菌株中的基因组序列、重排和拷贝数变化；染色体构象捕获将显示大规模重排如何影响 3D 结构；深度测序技术将序列和结构与基因表达和亚型丰度联系起来。计算分析将确定高适应度的进化驱动因素，并具有进一步优化的潜力。 IESY 以国际 Sc2.0 联盟独有的资源为基础，将成为高价值表型高效进化的国际资源。该项目代表了合成生物学的新范例，其中基因组被预先编程以探索组合多样性空间以进化新的有用功能。